Theravance Biopharma, Inc. (TBPH)
17.81
-0.31
(-1.71%)
USD |
NASDAQ |
Dec 09, 16:00
17.80
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma EPS Diluted (Quarterly): 0.0696 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Skye Bioscience, Inc. | -0.3216 |
| FibroGen, Inc. | 36.71 |
| Myomo, Inc. | -0.0869 |
| VYNE Therapeutics, Inc. | -0.1701 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.615M |
| Revenue (Quarterly) | 19.99M |
| Total Expenses (Quarterly) | 16.38M |
| Enterprise Value | 617.39M |
| Gross Profit Margin (Quarterly) | 92.96% |
| Profit Margin (Quarterly) | 18.08% |
| Earnings Yield | 3.16% |
| Normalized Earnings Yield | 3.158 |